Prostate Cancer is one of the leading causes of death in men, responsible for about 1 in every 44 deaths. But, it's one of the few cancers that is completely curable. Mark was 51 years old when diagnosed with prostate cancer in 2015. Now, almost a decade later he is online to tell his story of how he was diagnosed, and what other men should expect on their path to being cured of this disease. He talks about how he learned about his cancer, the surgery that saved his life, and how he manages ...
…
continue reading
A urology podcast, focussing on all things prostate, kidney, bladder, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org
…
continue reading
1
Radical prostatectomy and the wave of new robots in China today
33:15
33:15
Play later
Play later
Lists
Like
Liked
33:15
In the second of our special episodes focussing on GU Oncology in China, we are delighted to welcome back our GU Cast China Editor. Professor Yao Zhu, who has put together this cracking epsiode focussing on radical prostatectomy in China. We are joined by Professor Ming Liu (Beijing Hospital, Beijing) and Professor Jiahua Pan (Ren Ji Hospital, Shan…
…
continue reading
This conversation is about the recovery process after prostate surgery. The speaker shares his personal experience and provides tips and advice for surviving post-surgery. He discusses waking up after surgery, the presence of a catheter, the recovery room, hospital stay, diet, bowel movements, continence, and erectile function. He emphasizes the im…
…
continue reading
1
We meet the Active Surveillor | Howard Wolinsky
36:08
36:08
Play later
Play later
Lists
Like
Liked
36:08
There are patient advocates and there are patient advocates, and then there is Howard Wolinsky! We chat with the inimitable Howard, medical journalist and very long-time active surveillance patient, about his varied interests in low-risk prostate cancer and prostate cancer diagnostics. He runs a great substack called The Active Surveillor with a re…
…
continue reading
1
#108 - How to Eat, Train and Prepare for Prostate Cancer Treatment
36:05
36:05
Play later
Play later
Lists
Like
Liked
36:05
This podcast episode provides tips and advice for individuals preparing for surgery or radiation for prostate cancer or recurrence of prostate cancer. The host, a prostate cancer survivor, shares his personal experience and the strategies he used to prepare his body for these procedures. The episode covers topics such as diet, exercise, Kegel exerc…
…
continue reading
1
#APCCC24 Conference Highlights | Part 2
1:06:10
1:06:10
Play later
Play later
Lists
Like
Liked
1:06:10
Part 2 of our Conference Highlight specials from the Advanced Prostate Cancer Consensus Conference, held in April 2024 in Lugano. This is our very favourite prostate cancer meeting and we are thrilled to bring you these highlight podcasts. In this episode we chat with Elena Castro, Nick James, Anthony Joshua, Bertrand Tombal, Silke Gillessen, Aurel…
…
continue reading
1
#107: I'm 4 Weeks into Proton Radiation for Prostate Cancer Recurrence
25:25
25:25
Play later
Play later
Lists
Like
Liked
25:25
Mark is halfway through his radiation treatment for recurrent prostate cancer. He shares his experience, how he feels, and what to expect for the second half. He discusses the decision to have radiation after a recurrence, the process leading up to it, and the difference between proton radiation and photon radiation. Mark emphasizes the importance …
…
continue reading
1
2024 EAU Prostate Cancer Guidelines - some big changes!!
47:52
47:52
Play later
Play later
Lists
Like
Liked
47:52
Pelvic lymph node dissection down-graded. Systematic prostate biopsies no longer recommended. More clarity around PSMA PET/CT for staging. Surgery no longer recommended for cN1 prostate cancer. Yep the recent updates to the EAU Prostate Cancer Guidelines had a lot of important changes for the global urology community to digest. So we invited EAU Pr…
…
continue reading
The first of two Conference Highlight specials from the Advanced Prostate Cancer Consensus Conference, held in April 2024 in Lugano. This is our very favourite prostate cancer meeting and we are thrilled to bring you these highlight podcasts. In this epsiode we chat with Silke Gillessen, Derya Tilki, Jochen Walz, Neha Vapiwala, Dingwei Ye, and the …
…
continue reading
The theme of this podcast is staying alive and dealing with prostate cancer. Mark shares his experience with treatment and offers words of wisdom for those who are newly diagnosed or facing recurrence. He emphasizes the importance of not letting the cancer get the better of you and staying positive throughout the journey. The podcast covers topics …
…
continue reading
1
GU Highlights at #ASCO24 | with Marty Schoen
35:00
35:00
Play later
Play later
Lists
Like
Liked
35:00
Didn't get to ASCO this year?? Us neither!! But not to worry, we checked in with Dr Marty Schoen who did, and brings us all the key highlights! Marty is a GU Medical Oncologist at the St Louis Veterans Affairs Medical Centre and the University of St Louis, Missouri. He runs through a smattering of stuff that caught his eye at ASCO this year. Thanks…
…
continue reading
1
#105: I've Started Radiation for Prostate Cancer Recurrence
33:11
33:11
Play later
Play later
Lists
Like
Liked
33:11
Summary Mark provides an update on his radiation treatment for recurrence of prostate cancer, sharing insights on ADT, radiation treatment, side effects, and emotional impact. He emphasizes the importance of seeking treatment and maintaining a positive outlook. Keywords prostate cancer, radiation treatment, ADT, side effects, emotional impact, trea…
…
continue reading
1
Pembro improves survival after nephrectomy | Huge news for Urologists
45:57
45:57
Play later
Play later
Lists
Like
Liked
45:57
For Urologists, there are not that many papers that come along where we can say - "this will almost immediately change my practice". But KEYNOTE-564 looks like one of those! A large phase III randomised trial of adjuvant pembro following nephrectomy for renal cell carcinoma in patients deemed at higher risk for recurrence. Regular listeners/viewers…
…
continue reading
1
En-bloc party! RCT of TURBT with Jeremy Teoh
29:46
29:46
Play later
Play later
Lists
Like
Liked
29:46
Should we remove bladder cancers piece-meal by chopping them into little pieces, or should we try and remove en bloc with a margin around the base?? This very nice randomised controlled trial from our friends in Hong Kong demonstrates that the recurrence rate is significantly lower if we use the all-too-rarely used en bloc technique. Dr Jeremy Teoh…
…
continue reading
1
Three big challenges in metastatic prostate cancer | Dr Alicia Morgans
38:04
38:04
Play later
Play later
Lists
Like
Liked
38:04
Today we have Dr Alicia Morgans, GU Medical Oncologist and Director of Survivorship at Dana Farber Cancer Institute, in the GU Cast studio for a chat. We wanted to ask Alicia to look forward and identify three big challenges we will face in metastatic prostate cancer over the next 5-10 years. What did we come up with??!! Tune in to find out!! Even …
…
continue reading
1
#104: Preparing for Radiation for Prostate Cancer Recurrence
22:31
22:31
Play later
Play later
Lists
Like
Liked
22:31
Mark discusses his upcoming radiation treatment for a possible recurrence of prostate cancer. He shares his experience with androgen deprivation therapy (ADT) and the minimal side effects he has encountered. Mark also explains the process of preparing for radiation, including the simulation and the use of a rectal balloon to protect the rectum. He …
…
continue reading
1
Metastatic prostate cancer in China today
40:48
40:48
Play later
Play later
Lists
Like
Liked
40:48
In the first of our special episodes focussing on GU Oncology in China, we are delighted to welcome our inaugural GU Cast China Editor. Professor Yao Zhu, to the GU Cast studio. Yao is a Urologist at Fudan University Shanghai Cancer Centre, and is well known to all of us at GU Cast and Peter MacCallum Cancer Centre. As part of our Gold Partnership …
…
continue reading
Great fun on the shores of Lake Lugano where the hosts of three of the best -known podcasts in GU Oncology get together for a chat! Declan and Renu from GU Cast, join with Brian and Tom from Uromigos, and Gill from Oncoalert. How did it all start? Why did it all start?! Best moments, worst moments etc. Tune if for a chat, and do please subscribe/li…
…
continue reading
1
#103: Prostate Cancer is Back, and Here's What I Am Doing About It
31:05
31:05
Play later
Play later
Lists
Like
Liked
31:05
Mark shares his experience with prostate cancer recurrence and his plan to beat it. He discusses his treatment plan, including hormone therapy and radiation therapy. He explains the different types of hormone therapy and their side effects. Mark also emphasizes the importance of exercise and diet in mitigating the side effects of hormone therapy. H…
…
continue reading
1
ProsTIC24 PSMA Theranostics Conference Highlights
47:21
47:21
Play later
Play later
Lists
Like
Liked
47:21
The 2nd ProsTIC Preceptorship is one of the most intense fora for the discussion of PSMA theranostics anywhere in the world! A biennial meeting in Melbourne with many of the world's leading experts in the field. Not just superb practical advice about how to get your prostate cancer theranostics program to the next level, but some amazing discussion…
…
continue reading
1
Proton therapy no better than standard prostate radiotherapy
29:57
29:57
Play later
Play later
Lists
Like
Liked
29:57
A new paper in the Journal of Clinical Oncology is reporting that the bowel and urinary side-effects of proton therapy (a high tech and very expensive type of radiotherapy), are no better than side-effects after standard high-quality radiotherapy (called IMRT). Quite a fuss on twitter when this paper came on line last week including from a fair few…
…
continue reading
1
ADT and cardiac risks (and how I sold my company for $1.4bn)
32:03
32:03
Play later
Play later
Lists
Like
Liked
32:03
Professor Neil Fleshner (University of Toronto) drops into the GU Cast studio in Melbourne for an intriguing discussion! First we cover off the underrated topic of cardiac risks in patients starting androgen deprivation therapy and how we can reduce these for the benefit of our patients. Then we talk to Neil about entrepreneurship and his journey i…
…
continue reading
This podcast episode discusses the impact of prostate cancer on sexual function and provides insights and advice on how to navigate the challenges. I shares my personal experience with prostate cancer surgery and emphasize the importance of open communication with medical professionals. The chapters cover topics such as preparing for surgery or rad…
…
continue reading
1
Happy days for metastatic bladder cancer | Enrique Grande and Andrew Weickhardt
32:23
32:23
Play later
Play later
Lists
Like
Liked
32:23
A big medical oncology love-in in the GU Cast studio today!! Professor Enrique Grande was visiting from MD Anderson Cancer Centre in Madrid to chat all about some of the sensational advances we have seen in metastatic bladder cancer in recent times. And we were also joined by old friend Professor Andrew Weickhardt from Austin Health in Melbourne to…
…
continue reading
1
High risk prostate cancer and mHSPC | With Axel Merseburger
26:48
26:48
Play later
Play later
Lists
Like
Liked
26:48
Axel Merseburger (Chief and Professor of Urology, Lubeck, Germany) was in Australia recently and popped into the GU Cast studio for a chat. Axel was at the USANZ ASM recently and also on a speaker tour supported by Janssen Pharmaceuticals, so we put together this Themed Podcast to pick his brains on high-risk prostate cancer and mHSPC in 2024. This…
…
continue reading
1
#101: Welcome to Mark's Prostate Cancer Experience
32:20
32:20
Play later
Play later
Lists
Like
Liked
32:20
This is my welcome episode, where I introduce myself as someone who was diagnosed with Prostate Cancer in 2015, and so far have been living a normal life after surgery. There are many details of this disease that men seem to not be able to find answers for, and I am here to help share my own experiences. 1 in 44 men will die from Prostate Cancer, b…
…
continue reading
Declan and Renu bring you lots of highlights and interviews from the Urological Society of Australia & New Zealand (USANZ) Annual Scientific Meeting (ASM) which took place last week in Adelaide. Almost 1000 delegates descended on this beautiful part of the world, famous for its beaches and wineries. Hear from Robert Nam, Paul Anderson, Nathan Lawre…
…
continue reading
1
What does a randomised trial tell us about prostate biopsy?
32:22
32:22
Play later
Play later
Lists
Like
Liked
32:22
Needle through the rectum or needle through the skin?? Transrectal vs transperienal prostate biopsy is certainly a hot topic in prostate cancer, with the vast majority of men having their biopsy through the rectum rather than through the skin. It is quick, cheap and easy (for the urologist and the health system), but leaves the patient at risk of s…
…
continue reading
Two of the highest profile presentations at the recent ASCO GU Meeting were the plenary presentations of the CONTACT 02 trial, and the Keynote-564 trial. Generally speaking, these were well received; indeed quite enthusiastically received in some quarters! Not however in the quarter of prolific oncology commentator and Haematologist/Oncologist & Pr…
…
continue reading
Renu caught up with lots of experts and friends at ASCO GU in San Francisco recently and brings you all the highlights. Hear from Toni Choueiri, Matt Cooperberg (on that debate on renaming low-grade prostate cancer), Todd Morgan, Neha Vapiwala, Morgan Roupret, Sophia Kamran, Morgan Roupret, Sam Washington, plus a great chat with Tyler Seibert while…
…
continue reading
1
Bringing LuPSMA earlier | ProsTIC/PCF/ICIS Global Webinar
1:23:00
1:23:00
Play later
Play later
Lists
Like
Liked
1:23:00
For all you enthusiasts of PSMA theranostics, we bring you another one of our fabulous ProsTIC/Prostate Cancer Foundation Global Webinars with some of the best minds in the business. This is the eighth of our collaborative webinars over the past four years and the focus today is bringing lutetium PSMA earlier in prostate cancer. Two keynote lecture…
…
continue reading
A must listen (actually a must WATCH!!) episode of GU Cast if you have any experience with the side-effects of treatment of prostate cancer. Whether you are a patient or loved one, or a surgeon/radiation oncologist/medical oncologist, or a nurse or allied health professional - then this is for you. Declan and Renu chat about "A Touchy Subject" with…
…
continue reading
We reveal the three winners of our APCCC Travel Awards 2024! These three trainees will be heading off to Lugano for the world's best prostate cancer meeting which takes place from 25-27 April on the shores of Lake Lugano.By Professor Declan Murphy & Dr Renu Eapen
…
continue reading
1
Reducing "useless" lymph node dissections with PSMA
45:11
45:11
Play later
Play later
Lists
Like
Liked
45:11
By Professor Declan Murphy & Dr Renu Eapen
…
continue reading
1
Last few days to enter our great APCCC Lugano giveaway!!!
1:24
1:24
Play later
Play later
Lists
Like
Liked
1:24
A quick message from Renu and Declan about our huge travel award giveaway to start the new year! Closing date Monday 15th Jan 2024 Full details on https://www.gucast.org/By Professor Declan Murphy & Dr Renu Eapen
…
continue reading
A truly great Christmas tradition is when Toni Choueiri and his merry band of GU Oncology Fellows at Dana Farber, drop their list of the Top 10 GU Oncology papers of the year. And true to form, Toni's tweet on Christmas Day contains an immaculate list of GU highlights of 2023. A great mixture of tumour types, some brave choices with a Phase 1 study…
…
continue reading
1
Christmas Special | Plus our big APCCC Giveaway!
34:12
34:12
Play later
Play later
Lists
Like
Liked
34:12
Our final podcast of 2023 and it's a big one!! Huge festive giveaway with three fully funded GU Cast travel awards to attend the APCCC in Lugano (April 2024) up for grabs. Alastair Lamb zooms in from Oxford to discuss prostate cancer spatial transcriptomics. Kiaran O'Malley (Mater Hospital, Dublin) drops into studio for a festive drink, and GU Cast…
…
continue reading
Dr Ashish Kamat (MD Anderson Cancer Centre, Houston), joins Declan and Renu to discuss a very nice paper recently published in European Urology Oncology overviewsing the role of lymph node dissection (LND) in GU oncology. Really nice piece of work led by Dr Amanda Myers along with a bunch of well known names in urologic oncology. A very succinct su…
…
continue reading
It has becoming a familiar refrain around the world , and is certainly good news for the prostate cancer community! This week, another androgen receptor pathway inhibitor (ARPI) became reimbursed for men with hormone-sensitive metastatic prostate cancer (mHSPC) in Australia. Darolutamide is already available for men with non-metastatic castration-r…
…
continue reading
1
Lymph node recurrence - what to do and when??! With Piet Ost, Shankar Siva and Michael Hofman
30:11
30:11
Play later
Play later
Lists
Like
Liked
30:11
SABR supremos Piet Ost and Shankar Siva join us to discuss the management of lymph node-only recurrence following primary treatment of prostate cancer. And of course our resident PSMA PET/CT guru Michael Hofman also turned up as himself and Piet love debating the merits of PSMA! How and when shoudl we image for biochemical recurrence? What are the …
…
continue reading
Prof Fred Saad (University of Montreal) drops in to chat about the interesting condition that is non-metastatic castration-resistant prostate cancer (nmCRPC). Which men are at risk of developing metastases? When should we use an AR pathway inhibitor? Why PSMA PET/CT should NOT be used. And hear his thoughts on "dabbling" in prostate cancer! Also jo…
…
continue reading
1
Big prostate cancer highlights from #ESMO23
38:07
38:07
Play later
Play later
Lists
Like
Liked
38:07
What a great ESMO for GU Oncology!! Declan caught up with some plenary speakers in Madrid to discuss the biggest topics. PSMA theranostics with Louise Emmett (ENZA-P) and Oliver Sartor (PSMAfore); ARPIs in biochemical recurrence with Steve Freedland (EMBARK), Morgan Roupret and Boris Hadaschik. Plus the latest negative immunotherapy trials in prost…
…
continue reading
The LuTectomy trial has just been published in European Urology, and as the GU Cast team have been very much involved, we thought we should dive into the details on today's podcast. LuTectomy is a clinical trial to evaluate the role of 177-Lutetium-PSMA prior to radical prostatectomy. Declan is the study co-PI along with Professor Michael Hofman, a…
…
continue reading
One of our most popular episodes in 2022 was "Patting the Hormone Therapy Shark" with author, surfer and prostate cancer survivor, Tim Baker. And a lot has happened in the 12 months since so we invited Tim back for a follow-up chat in this Themed Podcast supported by our GU Cast Gold Partners, Mundipharma. Tim's inspiring approach to managing the s…
…
continue reading
1
Three big questions in high-risk prostate cancer | With Boris and Tyler
50:01
50:01
Play later
Play later
Lists
Like
Liked
50:01
We hijacked our good friends Professor Boris Hadaschik (Urologist, Essen, Germany), and Associate Professor Tyler Seibert (Radiation Oncologist, University of California, San Diego), who happened to be in Melbourne this week, and diverted them into the GU Cast studio for a chat about high-risk prostate cancer. Boris and Tyler were on a speaker tour…
…
continue reading
The European Association of Nuclear Medicine (EANM) Annual Meeting is the World's leading nuclear medicine extravaganza! Today we cross live to Professor Michael Hofman and friends to hear some of the GU highlights at this year's annual meeting in Vienna. Michael is joined by Prof Ken Herrmann, Dr Kerry Jewell, Dr Francesco Ceci, Dr Phiilip Kuo, Dr…
…
continue reading
The mass media were quick to pick up on two papers in JAMA Surgery last week with headlines such as "Patients have better outcomes with female surgeons", and "Should you pick the sex of your surgeon?". So what's it all about?? We chat with lead author of one of these papers. Dr Chris Wallis, Urologist at the University of Toronto, whose looked at o…
…
continue reading
1
Let's skip PSA testing! And go straight to an MRI scan...
32:08
32:08
Play later
Play later
Lists
Like
Liked
32:08
Is this the solution to screening for prostate cancer?? Don't bother with a PSA test and instead screen using a 10 minute MRI scan??! Re-IMAGINE is a very interesting prospective study published in BMJ Oncology this week which did exactly that with some really interesting findings. We are joined by study authors Professor Caroline Moore and Profess…
…
continue reading
1
Spacing the Rectum! With Peter Orio & Shankar Siva
25:13
25:13
Play later
Play later
Lists
Like
Liked
25:13
What is a rectal spacer and do they help reduce side-effects from prostate radiation??! That's today's topic on GU Cast. Renu caught up with rectal spacer enthusiasts Professor Peter Orio (Dana Farber Cancer Institute) and Associate Professor Shankar Siva (Peter MacCallum Cancer Centre) in downtown Melbourne this week to learn all about this topic.…
…
continue reading
1
The European Urology Podcast is coming soon!!
3:32
3:32
Play later
Play later
Lists
Like
Liked
3:32
Here's a quick plug for another podcast that GU Cast is very happy to support! Launching in September 2023, the European Urology Podcast is a new monthly podcast to accompany the world's highest ranked urology journal, European Urology. Co-hosted by Professor Declan Murphy in Melbourne and Dr Joyce Baard in Amsterdam, the European Urology Podcast w…
…
continue reading
Major scientific journals only change their Editor-in-Chief every 8-10 years so it's quite a big deal when it happens! Today we chat with Professor Alberto Briganti, incoming Editor-in-Chief of European Urology, the world's highest ranked urology journal, and with Professor Morgan Roupret, incoming Editor-in-Chief of European Urology Oncology. Why …
…
continue reading